These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5510745)

  • 1. [Thermographic data in Raynaud's syndrome. Initial results in Lyon].
    Thiers H; Schmitt M; Fayolle J
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):462-4. PubMed ID: 5510745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Contribution of a thermographic examination using an AGA apparatus in Raynaud's disease and Raynaud's syndrome].
    Zavrel B
    Cesk Radiol; 1983 Jun; 37(4):219-22. PubMed ID: 6883568
    [No Abstract]   [Full Text] [Related]  

  • 3. [A study of Raynaud's syndrome using dynamic infrared thermography].
    Shcherbakov AB; Koreneva LG; Markov AG
    Revmatologiia (Mosk); 1990; (2):7-11. PubMed ID: 2218268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic value of thermography in Raynaud's phenomenon associated with systemic lupus erythematosus].
    Mikulska D
    Ann Acad Med Stetin; 2009; 55(3):23-7. PubMed ID: 20698174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermographic parameters in the diagnosis of secondary Raynaud's phenomenon.
    Schuhfried O; Vacariu G; Lang T; Korpan M; Kiener HP; Fialka-Moser V
    Arch Phys Med Rehabil; 2000 Apr; 81(4):495-9. PubMed ID: 10768542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thermography in evaluating therapy in Raynaud's disease].
    Litmanovitch J; Shilo R; Chayen M
    Harefuah; 1972 Jun; 82(11):503-6. PubMed ID: 5068900
    [No Abstract]   [Full Text] [Related]  

  • 8. [Trial of a new drug in Raynaud's disease. Clinical and thermographic control].
    Dumoulin J
    Electrodiagn Ther; 1981; 18(4):168-74. PubMed ID: 6279383
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of a-sympathicolysis in Raynaud's syndrome].
    Westermann KW; Langbehn A; Feige A; Priester G
    Verh Dtsch Ges Inn Med; 1973; 79():1395-7. PubMed ID: 4275201
    [No Abstract]   [Full Text] [Related]  

  • 10. The 'distal-dorsal difference': a thermographic parameter by which to differentiate between primary and secondary Raynaud's phenomenon.
    Anderson ME; Moore TL; Lunt M; Herrick AL
    Rheumatology (Oxford); 2007 Mar; 46(3):533-8. PubMed ID: 17018538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative thermographic assessment of inositol nicotinate therapy in Raynaud's phenomena.
    Ring EF; Bacon PA
    J Int Med Res; 1977; 5(4):217-22. PubMed ID: 881094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of Raynaud's Syndrome with prostacyclin.
    Belch JJ; Newman P; Drury JK; Capell H; Leiberman P; James WB; Forbes CD; Prentice CR
    Thromb Haemost; 1981 Jun; 45(3):255-6. PubMed ID: 7025341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of thermographic tests in the diagnosis of the vascular vibration syndrome].
    Langauer-Lewowicka H
    Med Pr; 1986; 37(5):321-6. PubMed ID: 3807781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serial computed thermography for Raynaud's phenomenon of patient with progressive systemic sclerosis (PSS)].
    Tomono N; Kuriyama T; Mori M; Takahashi Y; Mitsuda T; Aihara Y; Yokota S
    Ryumachi; 1996 Jun; 36(3):522-7. PubMed ID: 8779789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of infrathermographic examination of the face and lower limbs in the differential-diagnosis of Raynaud's phenomenon caused by vibration and systemic disease.
    Kákosy T; Boczán J
    Med Lav; 1983; 74(6):499-502. PubMed ID: 6674720
    [No Abstract]   [Full Text] [Related]  

  • 16. Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon.
    Wesseling H; den Heeten A; Wouda AA
    Eur J Clin Pharmacol; 1981; 20(5):329-33. PubMed ID: 7026260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative thermal imaging to assess inositol nicotinate treatment for Raynaud's syndrome.
    Ring EF; Porto LO; Bacon PA
    J Int Med Res; 1981; 9(6):393-400. PubMed ID: 7319129
    [No Abstract]   [Full Text] [Related]  

  • 18. [Raynaud's phenomenon and systemic lupus erythematosus (author's transl)].
    Zitnan D; Tauchmannová H; Lukác J; Cebecauer L; Rovenský J
    Bratisl Lek Listy; 1981 May; 75(5):529-37. PubMed ID: 7237182
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of thermographic criteria to identify Raynaud's phenomenon in a population setting.
    Cherkas LF; Carter L; Spector TD; Howell KJ; Black CM; MacGregor AJ
    J Rheumatol; 2003 Apr; 30(4):720-2. PubMed ID: 12672189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of thermography and endothelin concentration in serum of children with Raynaud's Syndrome].
    Biernacka-Zielinska M; Brozik H; Smolewska E; Mikinka M; Jakubowska T; Stanczyk J
    Med Wieku Rozwoj; 2005; 9(2):213-22. PubMed ID: 16085962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.